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ABSTRACT 
The present study is very expectant towards the development of co-encapsulated liposomal formulation. The assay method for artesunate has a 
challenge because it doesnot have a readily recognisable absorption chromophore needed for UV spectroscopy. Curcumin, a lipid soluble 
antioxidant, exhibits solvent and medium sensitive absorption and fluorescence properties. A simple and rapid method involving two reaction steps 
has been developed for assay of artesunate and curcumin combination in liposomal formulation. Stock solution of artesunate and curcumin were 
diluted to final concentration of 10 µg/ml. The UV scan of 10 µg/ml solution of artesunate and curcumin combinations showed the absorbtion 
maxima at 240 nm and 425 nm respectively. The coloured complex obeyed the Beer’s law in the concentration range of 2-20 µg/ml. The above 
methods is rapid tool for routine analysis of artesunate and curcumin in novel carrier system. The recovery studies confirmed the accuracy and 
precision of the methods. 
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INTRODUCTION 
The artemisinin-based combination therapies (ACTs) are currently 
recommended by the World Health Organization as the first-line 
treatment for Plasmodium falciparum malaria. Since 2010, five ACTs 
are marketed namely: artemether plus luCURantrine, artesunate 
plus amodiaquine, artesunate plus CURloquine, artesunate plus 
sulfadoxine-pyrimethamine and dihy-droartemisinin plus 
piperaquine.[1] Several reasons including cost considerations, 
pharmacokinetic mismatch, resistance, cross-resistance and side 
effects due to the partner drug of artemisinin-type compounds, 
many efforts are invested to discover new companion drug. In the 
same way, Curcumin loaded lipid-based formulations were also 
developed to improve the bioavailability of Curcumin at the target 
site. In order to guarantee the quality, safety and efficacy of 
curcumin (CUR) and artesunate (ART) in these promising 
antimalarial lipid-based formulations, it is mandatory to have a 
suitable analytical procedure. 
Curcumin (CUR, 1), 1, 7-bis (4-hydroxy-3-methoxyphenyl)-1, 6-
heptadien-3, 5-dione, is a polyphenol derived from the herbal 
remedy and dietary spice turmeric (Curcuma longa). It possesses 
diverse anti-inflammatory and anti-cancer properties following oral 
or topical administration.[1] Turmeric and curcumin are reported to 
be potent anti bacterial and anti hepatotoxic agents.[2] Chemically 
artesunate was (3R,5aS,6R,8aS,9R, 10S,12R,12aR)-Decahydro-3,6,9 
trimethyl-3,12-epoxy-12 H-pyrano[4,3-j]-1,2-benzodioxepin-10-ol, 
hydrogen succinate.[3] Artesunate and its active metabolite 
dihydroartemisinin are potent blood schizonticide active against the 
ring stage of the parasite. 
 
 
Fig. 1: Structure of Curcumin 
 
There was no any method has been reported for simultaneous 
estimation of both drug by UV Spectrophotometric method. This 
paper describes a simple, accurate, sensitive and validated UV 
Spectrophotometric method for simultaneous quantification of these 
compounds as the bulk drug and in combined dosage forms. The 
proposed method is optimized and validated as per the International 
Conference on Harmonization (ICH) guidelines [4-5]. 
 
 
Fig. 2: Structure of artesunate 
 
MATERIALS AND METHODS 
Drugs and chemicals 
A standard drug sample of curcumin was purchased from Chemdye 
Lab and artesunate were provided as gift from IPCA Pharma, 
Mumbai. All chemicals and solvents used of AR grade. 
UV-spectrophotometer UV-1700(Shimadzu, Japan) with spectral 
band-with of 2 nm and 10 nm matched quartz cell was used for the 
development analytical method over the range of 800-200 nm. 
Optimized liposomal formulation containing artesunate and 
curcumin (1:1) was used as sample. Calibrated borosilicate 
glassware was used during experimental study. 
Standard stock solution of ART 
1. 0.1 N sodium hydroxide: 0.42 g of sodium hydroxide was weighed 
and dissolved in distilld water and made up to 100 ml. 
2. 0.1 Macetic acid in 20% Methanol: 1.114 ml of glacial acetic acid 
was measured and diluted to 200 ml with methanol. 
Decomposition reaction: Basic decomposition followed by acid 
reaction 
The method applied in this study is modified methods used by Zhao 
in HPLC assay of artemisinin from plasma and saliva [6]. 10 mg ART 
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was accurately weighed, dissolved in methanol and made up to 10 
ml to give a concentration of 1000 mcg/ml. One mililiter of the 
solution was transferred to a 10 ml volumetric flask containing 4 ml 
of 0.1 N Sodium hydroxide. The flask was placed in the water bath at 
50±2 °C for 1 hr. The solution was allowed to cool and made up to 
volume with 0.1 M acetic acid in 20% methanol. The stock solution 
was diluted to the 10, 20. 60 µg/ml concentrations with 0.1 M acetic 
acid in 20% methanol. 
Standard stock solution of CUR 
An accurately weighed quantity of 10 mg of CUR was taken in 10 ml 
volumetric flask dissolved in sufficient quantity of methanol and 
diluted to 10 ml with the same solvent so as to get the concentration 
of 1000 μg/ml. 
Determination of λ max of ART and CUR 
The standard solution of CUR was scanned in the range of 800-200 
nm and the λ max was found to be 425 nm against methanol. 
Similarly, the standard solution of ART was scanned in the range of 
800-200 nm and the λ max was found to be 240 nm against0.1 M 
acetic acid in 20% methanol. 
Analysis of mix standard (ART and CUR) and formulation 
The method was checked by analysing a solution congaing the 
known concentration of both drugs. The mixed standard in Beer-
Lambert’s range for each drug in the ratio of 1:5 containing 10, 30, 
60 µg/ml of ART and 2, 6, 12 µg/ml of CUR respectively was 
prepared by diluting appropriate volumes of standard stock 
solution. Liposomes were prepared by film hydration methods by 
using rotary vacuum evaporator and optimized to the ratio of drug: 
Cholesterol: PEG: Soya lecithin in 1:10:15:30.  
The % entrapment of artesunate and curcumin was found to be 
96.42 and 95.78 respectively. Drug associated with liposome was 
separated from unentraped drug using centrifugation methods. 
Liposomes were centrifuged at 20000 RPM for 1 hr at controlled 
temperature 4 °C.  
Supernatant containing unentrapped drug suspension was 
withdrawn and diluted first with 10 ml methanol and second 
according to decomposition reaction. Various dilutions of the mix 
standard and formulation stock solutions were scanned and the 
absorbances of these solutions were measured at 240 nm and 425 
nm respectively. The concentration of ART and CUR present in 
mixed standard was calculated using simultaneous equation.  
Method validation 
The method was developed and validated according to analytical 
procedure as per the ICH guidelines [9-10] for validation of 
analytical procedures in order to determine linearity, precision, LOD, 
LOQ and accuracy for the analyte. 
 
   
Fig. 3: λ max of ART Fig. 4: λ max of CUR Fig. 5.: Overlay spectrum of ART, CUR and Formulation 
 
Table 1: Standard calibration table of ART and CUR 
S. No. For artesunate conc. (μg/ml) Abs*at 240 nm For curcumin conc. (μg/ml) Abs at 425 nm 
1 10 0.007 02 0.162 
2 20 0.015 04 0.321 
3 30 0.024 06 0.483 
4 40 0.032 08 0.658 
5 50 0.040 10 0.804 
6 60 0.049 12 0.958 
* each value is a mean of three observation 
 
 
Fig. 6: Calibration curve of Artesunate at 240 nm 
 
Fig. 7: Calibration curve of curcumin at 425 nm
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Table 2: Optical and line equation parameter 
Parameter Artesunate Curcumin 
Working Wavelength 240 425 
Linearity Range (μg/ml)  10-60 02-12 
MolarAbsorptivity (mol-1 cm2 (9.153±0.59) x 10) 48000 2 
Limit of Detection (μg/ml) 0.54 0.45 
Limit of Quantitation(μg/ml) 1.79 0.48 
Y=mx+c   
Slop 0.000 0.080 
Regression Coefficient 0.997 0.999 
 
Table 3: Absorbance of mixed standard (ART+CUR) 
S. No. Mix Standard Abs at 240 nm Abs at 425 nm 
Conc. of ART(μg/ml) Conc. of CUR (μg/ml) 
1 10 02 0.008 0.164 
2 30 06 0.025 0.485 
3 60 12 0.048 0.956 
 
Table 4: Result of mixture containing ART and CUR 
S. No. Amount present (μg/ml) Amount found (μg/ml) % Amount found 
 ART CUR ART CUR ART CUR 
1 10 02 9.96 1.94 99.6 97.00 
2 30 06 29.85 5.78 99.5 96.33 
3 60 12 59.90 11.84 99.83 98.66 
 
Table 5: Result of optimized liposomal formulation 
S. No Label claim (mg/ml) Amount found (mg/ml) % Label Claim 
 ART CUR ART CUR ART CUR 
1 1 2 0.98 1.97 98 98.5 
2 2 4 1.96 3.98 98 99.5 











Table 6: Result of recovery studies 
Level of % recovery Amount present(mg/ml) Amount of standard added (mg) Total amount recovered (mg) % Recovery 
 ART CUR ART CUR ART CUR ART CUR 
80 1 2 0.8 1.6 1.78 3.59 98.8 99.7 
100 2 4 1.0 2.0 2.98 5.89 99.3 98.2 
120 3 6 1.2 2.4 4.19 8.38 99.7 99.7 
 Mean 99.26 99.2 
 SD 0.531 0.86 
 %RSD 0.535 0.87 
 
RESULTS AND DISCUSSION 
A) Linearity 
From the standard stock solutions containing 1000 μg/ml of ART 
and 1000 μg/ml of CUR dilutions were made to prepare the range of 
standard solutions having different concentrations of ART (10-60 
μg/ml) and CUR (02-12 μg/ml). The absorbance was measured at 
240 nm (λ max of ART) and at 425 nm (λ max
B) Precision 
 of CUR) respectively. The 
results obtained are shown in table No.1. The linearity of the 
relationship between absorbance and concentration was determined 
by plotting the calibration curve for ART and CUR respectively. The 
calibration curves are shown in fig. 6 and 7. 
Repeatability of the method was established by analyzing various 
replicates samples of ART and CUR. Precision was carried out by 
performing Interday variation and intraday variation. In Interday 
variation the sample was analyzed on three consecutive days. In intraday 
and variation the absorbance were measured three times in a day. The 
results for intraday and interday precision are shown in table No.7. 
C) Limit of detection 
The Limit of Detection (LOD) is the smallest concentration that can 
be detected but not necessarily quantified as an exact value. LOD 
was calculated using the following formula:  
           3.3 x Std deviation of Y Intercept 
LOD=----------------------------------------------- 
         Slope of calibration curve 
The limit of detection of ART and CUR are as follows:  
ART: 0.54 μg/ml, CUR: 0.45 μg/ml 
D) Limit of quantitation 
The Limit of Quantification (LOQ) is the lowest amount of analyte in 
the sample that can be quantitatively determined with suitable 
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precision and accuracy. LOD was calculated using the following 
formula:  
         10 x Std deviation of Y Intercept 
LOD=----------------------------------------------- 
Slope of calibration curve 
The limit of detection of ART and CUR are as follows:  
ART: 1.79 μg/mlCUR: 0.48 μg/ml 
E) Recovery studies 
Recovery studies were carried out by standard addition method at 
three levels, 80%, 100%, and 120%. In this method, a known 
amount of standard drug solution were added to Liposomal 
suspension and absorbance was measured at 240 nm and 425 nm (λ. 
max of ART and CUR respectively) and the concentration of both 
drugs can be determined.  
At each level three determinations were performed and results were 
obtained. The results for recovery studies were given in table No.6. 
 
Table 7: Result of intermediate precision 




ART Mean 99.58 99.68 
 SD 0.3176 0.3722 
 %RSD 0.3189 0.3732 
CUR Mean 100.24 99.59 
 SD 0.5656 0.2504 
 %RSD 0.5644 0.2516 
 
The linearity of ART and CUR was observed in the range of 20-
140μg/ml and 50-350μg/ml respectively with correlation coefficient 
0.9954 & 0.994 for ART and CUR respectively. Detection wavelength 
used was 242 nm for ART and 256 nm for CUR. The LOD and LOQ 
values for ART were 0.54μg/ml & 1.79μg/ml. For CUR the LOD and 
LOQ values were 0.45μg/ml & 0.48μg/ml. 
CONCLUSION 
A simple, precise, accurate and economic UV method was developed and 
validated for estimation of Artesunate and curcumin from bulk and 
formulation. The method was validated as per ICH guidelines by using 
various validation parameters such as Linearity, accuracy, precision, 
LOD, LOQ. The LOD and LOQ values for ART were 0.54μg/ml & 
1.79μg/ml. For CUR the LOD and LOQ values were 0.45μg/ml & 
0.48μg/ml. the method was validated as per ICH guideline. 
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